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Expression of the opioid peptide genes proopiomelanocortin (Pomc), proenkephalin (Penk),
and prodynorphin (Pdyn), in immune cells plays a key role in endogenous pain control. In a
rat model of painful unilateral paw inflammation, we isolated cells from popliteal lymph
nodes and evaluated the role of CpG island C5-methylation on the transcriptional activation
of those genes. Using methylated DNA immunoprecipitation, we sorted gDNA into methyl-
ated (me) and non-me fractions and then determined the CpG island methylation status of
each fraction via quantitative Real Time-PCR (qRT-PCR). In silico analysis by MethPrimer
software identified one CpG island in Pdyn and three each in Pomc and Penk. No substantial
changes in C5-methylation of any gene were observed. In conclusion, the CpG island meth-
ylation status does not seem to be a key regulator of opioid gene activation in immune cells
during peripheral tissue inflammation.
Introduction
The expression of endogenous opioid peptides in peripheral tissue can play an important role
in pain control [1–3]. In acute inflammation, immune cells express the three opioid peptides
beta-endorphin (END), Met-enkephalin (MENK) and Dynorphin A (DynA) [4–10]. Upon
their release, antinociception is triggered through binding of the opioid peptides to their corre-
sponding receptors on peripheral sensory nerve endings [11,12].
The opioid peptides END, MENK and DynA are encoded by proopiomelanocortin (Pomc),
proenkephalin (Penk) and prodynorphin (Pdyn), respectively. The main expression of Pomc
occurs in the pituitary gland where it is regulated e.g. by the transcription factors TPIT and
PITX1 [13–15]. Pdyn and Penk are also predominantly expressed in the brain. In addition, all
endogenous opioids are synthesized site-specifically in various organs [16–19].
So far, research has been focusing on transcriptional regulation of opioid peptide genes in
the brain or on the liberation of opioids from immune cells, but little is known about the tran-
scriptional regulation of opioid gene expression in immune cells.
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All three opioid genes are, under certain circumstances, transcriptionally regulated by
methylation [20–25]. The most common form of DNA methylation is the addition of a methyl
group to the C5 position of cytosine within a CpG dinucleotide which mostly occurs outside
CpG islands [26]. The latter is defined as a short interspersed DNA stretch containing
increased amounts of CpG dinucleotides with a GC content> 0.5 and an observed vs. expected
CpG ratio > 0.6 [27].
Earlier studies showed an upregulation of opioid gene expression in popliteal lymph nodes
(LNs) after peripheral inflammation [10,28,29]. To investigate a possible transcriptional regu-
lation via methylation, this paper focusses on total CpG island methylation of gDNA of Pomc,
Penk and Pdyn in isolated CD45RA± cells of naïve and inflamed popliteal LNs.
Materials and methods
Animal housing and induction of inflammation
Animal housing and experiments were carried out after approval by the local animal care com-
mittee (Landesamt fu¨r Gesundheit und Soziales, Berlin; H0370/09) and strictly met the guide-
lines of the International Association for the Study of Pain [30]. Male WISTAR rats (Janvier
Labs) were kept in cages lined with ground corncob bedding with standard laboratory rodent
chow and tap water available ad libitum. A light cycle of 12/12 hours light/dark, room tempera-
ture of 22˚C and humidity between 40–60% were maintained. Under brief anesthesia with
Forene1 (Abbvie) rats received an intraplantar injection of 0.15 ml Freund’s Complete Adju-
vant, Modified, Mycobacterium butyricum (CFA) (Merck Millipore) into the right hind paw.
After 96 h of inflammation, animals were killed by an overdose of inhalation anesthesia
(Forene1). Naïve animals were left untreated.
Preparation of CD45RA+- cells from LNs
In case of CFA-injected animals, the popliteal LN of the right hind paw, and in case of naïve ani-
mals, both popliteal LNs and the cervical LNs were dissected and kept on ice in RPMI 1640
medium (Gibco). Cell suspensions were prepared by homogenizing LNs with scalpel blades and
plastic pestles. Remaining cell clumps were excluded using 70 and 40 μm cell strainers. Cells
were counted using a Neubauer Chamber, centrifuged and resuspended in 80 μl cold RPMI
1640 medium per 107 cells. Magnetic cell sorting was performed using rat CD45RA MicroBe-
ads, MS or LS columns, the VarioMACS Separator and the MACSmix Tube Rotator (all Milte-
nyi Biotec) following the manufacturer’s protocol and using RPMI 1640 medium instead of
buffer. Collected cells from flow-through and eluate fractions were pelleted at 450 x g for 10
min (4˚C), washed with PBS (Gibco) and stored in 1.5 ml tubes at– 80˚C until further use.
gDNA isolation and shearing
The isolation of gDNA from CD45RA+ or CD45RA- cells was performed by adding 700 μl
lysis buffer (50 mM Tris-HCl; pH 7.5); 100 mM EDTA; 100 mM NaCl; 1% SDS) and 0.5 μg/μl
proteinase K to a frozen cell pellet, followed by incubating at 55˚C until the pellet was lysed.
The lysate was ultrasonicated for 2 x 20 s at 70% power using the SONOPULS Ultrasonic
homogenizers (BANDELIN) before centrifuging for 15 min at 2500 x g. The supernatant was
transferred to a fresh 2 ml tube and NaCl was added to a final concentration of 1 M. For
gDNA precipitation 1 vol of isopropanol was added, mixed by inverting the tube and centri-
fuged for 15 min at 2500 x g. The supernatant was discarded and the pelleted gDNA was
washed twice with 70% EtOH (15 min; 4˚C; 2500 x g). The gDNA pellet was dried at room
temperature and dissolved in TE buffer (10 mM Tris; 1 mM EDTA; pH 8).
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Methylated DNA immunoprecipitation
For gDNA shearing the gDNA was diluted in TE buffer to a final concentration of 0.1 μg/μl
and 300 μl were ultrasonicated to a mean size of about 500 bp. The size of DNA was verified
on 1% agarose gels using electrophoresis. Methylated DNA immunoprecipitation (MeDIP)
was performed using the MethylCap kit and the Diagenode Magnetic Rack (both Diagenode)
according to the manufacturer’s manual. For elution of the methylated (me) gDNA fraction
only High Elution Buffer was used. To purify DNA after MeDIP the QIAquick PCR Purifica-
tion Kit (Qiagen) was utilized following the manufacturer’s instructions. To elute DNA the
columns were loaded twice with 50 μl PCR grade H2O. All gDNA samples were stored at 4˚C.
CpG island prediction
To predict CpG island positions for Pomc, Penk and Pdyn the MethPrimer software [31] was
used. The following Ensembl sequences [32] were analyzed: ENSRNOT00000016976 (Pomc);
ENSRNOT00000089318 (Penk); ENSRNOT00000037576 (Pdyn).
qRT-PCR
For qRT-PCR the Mastercycler1 ep realplex, twin.tec 96 real-time-PCR Plates, Masterclear1
real-time-PCR Films (all Eppendorf) and the universal EXPRESS SYBR1 GreenER™ qPCR
Supermix (Life Technologies) were used with the following PCR program: 2 min 50˚C; 2 min
95˚C; 15 s 95˚C; 10 s 61˚C; 20 s 78˚C; 50 cycles. An additional melting-curve-analysis was per-
formed. A standard 20 μl reaction contained 1 x SYBR Mix, 0.2 μM primer and 2 μl gDNA/
PCR grade H2O. Primers (TIB MOLBIOL) and sequences (forward (F)/ reverse (R)) are listed
in Table 1. Rat histone H2B type 1-A (TSH2B) and glyceraldehyde-3-phosphate dehydrogenase
(Gapdh) primers (Diagenode) served as positive control for me and non-me gDNA, respec-
tively. Relative transcript levels were sustained by subtracting the threshold cycle (Ct) value of
the total input from the corresponding Ct value of the gDNA-IP. Differences in gDNA levels
were calculated according to the expression 2-ΔCt.
Table 1. CpG islands in rat opioid genes and corresponding primers/ sequences.
gene CpG island genomic region primer name oligonucleotide sequence
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Statistics
The Shapiro-Wilk normality test followed by Friedman Test and Dunn’s multiple comparison
test were performed to evaluate statistical significance within a group of naïve or CFA samples.
To compare between naïve and CFA samples the Mann-Whitney U test was performed. p val-
ues<0.05 were considered significant. Data were expressed as means ± SD. Statistics were per-
formed using GraphPad Prism version 5.02 for Windows (San Diego, California, USA).
Results
CpG island detection in rat opioid genes
Using the MethPrimer software for identifying CpG islands within the three opioid peptide
coding rat genes, three CpG islands were found in each Pomc and Penk, and one in Pdyn (Fig
1A) (Table 1).
Fig 1. CpG island determination in rat opioid genes and methylation status of Pomc CpG islands in CD45RA± LN cells of naïve and CFA-
treated rats. Schematic structure (a) of Pomc, Penk and Pdyn including exons (E1-3, highlighted in grey), calculated CpG islands (CpG1-3,
highlighted in black) and qRT-PCR amplicon positions (├┤). For Pomc CpG1 (b) and Pomc CpG2 (c) one amplification region was selected each,
and two were selected for Pomc CpG3 (3.1 and 3.2) (d+e) using qRT-PCR. Means ± SD; /# P< 0.05; /## P< 0.01;  P< 0.001; Friedman test
with Dunn’s multiple comparison post hoc test ( non-me vs. me) and MWU test (# CFA vs. naïve); n = 7 (a, b, c+d naïve), n = 8 (c+d CFA).
https://doi.org/10.1371/journal.pone.0191698.g001
Methylation of opioid peptide genes in a model of inflammatory pain
PLOS ONE | https://doi.org/10.1371/journal.pone.0191698 January 19, 2018 4 / 10
Methylation of Pomc
Under all conditions the majority of DNA fragments was found in the non-me fractions (albeit
not always statistically significant) and CFA treatment resulted in decreased amounts of me
DNA (Fig 1B–1E). The latter differences were statistically significant in CD45RA- cells (CpG1
+3) (Fig 1B, 1D and 1E). CFA treatment significantly increased the number of amplicons in
the non-me fraction of CpG3.2 in CD45RA
+ cells (Fig 1E). Differences between CD45RA- and
CD45RA+ cells were not observed.
Methylation of Penk
The majority of DNA for Penk in CpG1+2 was not methylated (Fig 2A–2C). CFA treatment
resulted in small (but statistically significant) decreases of me DNA in CpG1+2 of CD45RA
+
cells and in CpG2 of CD45RA
- cells (Fig 2B and 2C). At CpG3 mainly me DNA was found (Fig
2D) with no differential expression resulting from CFA treatment. No differences between
CD45RA- and CD45RA+ cells were observed.
Methylation of Pdyn
DNA in the Pdyn CpG island almost exclusively amplified in the me DNA fraction under all
conditions (Fig 3A). In naïve cells, this difference was statistically significant. No differences in
methylation status between CFA-treated and naïve LN or between CD45RA- and CD45RA+
cells were found.
Fig 2. Methylation status of Penk CpG islands in CD45RA± LN cells of naïve and CFA-treated rats. For Penk CpG1 two amplification regions
1.1 (a) and 1.2 (b) were selected, and one region each for Penk CpG2 (c) and Penk CpG3 (d) were chosen for qRT-PCR. Means ± SD; /# P< 0.05;
/## P< 0.01; Friedman test with Dunn’s multiple comparison post hoc test ( non-me vs. me) and MWU test (# CFA vs. naïve); n = 7 (a, c, d, b
naïve) and n = 8 (b CFA).
https://doi.org/10.1371/journal.pone.0191698.g002
Methylation of opioid peptide genes in a model of inflammatory pain
PLOS ONE | https://doi.org/10.1371/journal.pone.0191698 January 19, 2018 5 / 10
MeDIP controls
The control amplification of the CpG site in Gapdh (Fig 3B) resulted in a nearly exclusive
enrichment in the non-me DNA fraction, whereas for TSH2B (Fig 3C) the accumulation
occurred only in the me DNA fraction. No differences in methylation status between CFA-
treated and naïve LN or between CD45RA- and CD45RA+ cells were found.
Discussion
Painful paw inflammation has been shown to increase the expression of Pomc mRNA and its
protein product END in immune cells of LNs draining an inflamed hind paw. In 2007, Sitte
et al. [10] showed the increased END production in LN cells after paw inflammation and the
expression of several splice variants of Pomc mRNA. Maddila et al., 2016 [33] showed that
mRNA expression of Pomc was upregulated in LN B-cells after inducing paw inflammation
and that mRNA and protein expression of the POMC processing enzymes PC1 and PC2 also
increased shortly thereafter. After 24 h of inflammation, a significant increase of END in LN
B-cells was confirmed. To further elucidate the underlying mechanisms, the present study
focused on DNA methylation, a common means of transcriptional regulation. Since not only
END but also ENK and DynA were shown to contribute to endogenous pain control through
immune cells [4,8] all three opioid peptide genes were investigated here.
To analyze DNA methylation not only the promoter regions were examined but also exons
and introns because alterations in methylation pattern of 5´-upstream regions can also influ-
ence transcription [34–36]. This has already been shown for POMC by Kuehnen et al., 2012
Fig 3. Methylation status of Pdyn CpG island in CD45RA± LN cells of naïve and CFA-treated rats and MeDIP controls. Relative DNA amounts
of the Pdyn CpG island DNA in each gDNA fraction were measured via qRT-PCR (a). gDNA separation via MeDIP was verified with control
primers for Gapdh (non-me) (b) and rTSH2B (me) (c). Means ± SD; # P< 0.05; /## P< 0.01;  P< 0.001; Friedman test with Dunn’s multiple
comparison post hoc test ( non-me vs. me) and MWU test (# CFA vs. naïve); n = 7 (a); n = 19 (b CFA); n = 18 (c CFA); n = 14 (b+c naïve).
https://doi.org/10.1371/journal.pone.0191698.g003
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[37], who found a hypermethylation at the boundary of intron 2 and exon 3 associated with
obesity. Also PENK expression was shown to be regulated by methylation in the first exon in
vitro [38].
Several forms of methylation are known, including 5-methylcytosine, 5-hydroxymethylcy-
tosine or the rather unfrequent N6-methyladenosine. Since 5-methylcytosine is the most prev-
alent and the regulation of all three opioid genes has been associated with C5-(de)methylation,
it was chosen for this study [23,25,39]. The in silico identification of CpG islands in all opioid
peptide genes (Fig 1A) also suggests epigenetic regulation.
Methylation of CpG islands is generally associated with gene silencing whereas demethy-
lation usually correlates with gene activation [40,41]. We therefore expected DNA hypo-
methylation in LN cells following CFA treatment. Our results show that there are no drastic
differences in methylation of opioid peptide genes with or without paw inflammation, or
between CD45RA+ and CD45RA- LN cells in both conditions. Several CpG sites in Pomc (Fig
1B–1D) and Penk (Fig 2B and 2C) show a small but statistically significant decrease in the
amount of me DNA comparing CFA-treated and naïve LN cells. Taking into account that in
all cases the majority of amplified DNA was found in the non-me DNA fraction, those differ-
ences do not seem to be of biological relevance. This suggests that epigenetic regulation via
methylation is not particularly prominent. However, a striking difference in the methylation
status comparing the different CpG islands of Penk has to be noted. Finding the upstream CpG
islands generally unmethylated but the downstream CpG3 highly methylated gives a hint that
DNA methylation does have a certain impact on Penk expression.
The following limitations need to be considered: We examined the general CpG island
C5-methylation status of the three major opioid peptide genes using MeDIP. The MeDIP
assay investigates defined DNA regions for cumulations of C5-methylation, but it is impossible
to look at single CpG dinucleotides or other methyl-associated DNA-modifications such as e.g.
5-hydroxymethylcytosine (5-hmC). Thus, only those transcriptional regulation processes can
be identified, which are mediated by general C5-(de)methylation of an entire DNA segment
including several CpG sites. However, transcriptional regulation can also be initiated by few or
single CpG sites [42,43]. To obtain information about single CpG methylation, two common
tools, DNA bisulfite modification or methyl-sensitive restriction enzymes could be used for
future analysis, keeping in mind that both strategies also have limitations. For example, not
every CpG site binds restriction enzymes. Bisulfite treatment would result in single CpG resolu-
tion. However, DNA degradation, high GC-contents and 5-hydroxymethylation hinder analy-
sis [44]. The MethylCap kit used here is limited by the quality of DNA and the MethylCap
protein. However, both are rather unlikely to influence our results. The DNA preparation was
checked using agarose gels and, next to the positive controls (Gapdh and TSH2B), both me and
non-me DNA sections were identified in the opioid peptide genes, thus supporting the func-
tionality of the assay and of the MethylCap protein in particular. A false contribution of hemi-
methylated DNA to the results is also unlikely, since the MethylCap protein has low affinity
for hemimethylated DNA [45] and mainly non-me regions were identified. PCR experiments
were conducted using specific primers, designed to each span the region with the greatest CpG
appearance. For CpG-islands longer than 300 bp, two amplification regions were chosen, in
both cases showing the same trend in the C5-methylation status.
Conclusion
In conclusion, CpG island C5-methylation is apparently not the key regulator of transcrip-
tional activation of opioid peptide genes in immune cells from rats with acute paw inflamma-
tion. The MeDIP assay is an appropriate tool to analyze the general methylation status of
Methylation of opioid peptide genes in a model of inflammatory pain
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specified genomic regions, as demonstrated by the opposing results for different CpG islands.
Nevertheless, our results cannot provide a general prediction without further experiments.
Investigations of single C5pG methylation, other methylation-based DNA modifications and
CpG island shores in different stages of inflammation are necessary to fully elucidate DNA
methylation as a regulating element of opioid peptide expression in immune cells.
Supporting information
S1 Table. Data sets for Figs 1–3. The table lists the individual values for each bar in Figs 1–3
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